GLP-1 receptor agonists are licensed to treat diabetes and obesity, but data on whether these medications alleviate or exacerbate anxiety, depression, and self-harm are mixed
A result of decades of groundbreaking research, Dr
However, a direct comparison of the BP-lowering effects of these two types of antidiabetic drugs has not been reported
The result is a mixture of intravascular and extravascular hemolysis: dark urine from free hemoglobin, jaundice from bilirubin, and falling hemoglobin levels [3,6]
The first versions of GLP-1s were injectable drugs that people had to give themselves weekly
Introduced in 2017 and approved by the FDA, Ozempic is an innovative medication specifically designed for the treatment of type 2 diabetes